⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8228086 | 0.69 | — | — | |
| SCHEMBL8293504 | 0.69 | — | — | |
| SCHEMBL17722510 | 0.67 | — | — | |
| SCHEMBL16774287 | 0.67 | — | — | |
| SCHEMBL15256490 | 0.67 | — | — | |
| SCHEMBL20234155 | 0.67 | — | — | |
| SCHEMBL14748076 | 0.67 | — | — | |
| SCHEMBL16246004 | 0.63 | — | — | |
| SCHEMBL7413147 | 0.63 | — | — | |
| SCHEMBL8698033 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009017838-A2 | COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS | EXELIXIS, INC. (US) | 2009-02-05 | — | — | WO | disclosed |